Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer.
Crippa A, De Laere B, Discacciati A, Larsson B, Connor JT, Gabriel EE, Thellenberg C, Jänes E, Enblad G, Ullen A, Hjälm-Eriksson M, Oldenburg J, Ost P, Lindberg J, Eklund M, Grönberg H. Crippa A, et al. Among authors: discacciati a. Trials. 2020 Jun 26;21(1):579. doi: 10.1186/s13063-020-04515-8. Trials. 2020. PMID: 32586393 Free PMC article.
One-stage dose-response meta-analysis for aggregated data.
Crippa A, Discacciati A, Bottai M, Spiegelman D, Orsini N. Crippa A, et al. Among authors: discacciati a. Stat Methods Med Res. 2019 May;28(5):1579-1596. doi: 10.1177/0962280218773122. Epub 2018 May 9. Stat Methods Med Res. 2019. PMID: 29742975
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.
Eriksson M, Eklund M, Borgquist S, Hellgren R, Margolin S, Thoren L, Rosendahl A, Lång K, Tapia J, Bäcklund M, Discacciati A, Crippa A, Gabrielson M, Hammarström M, Wengström Y, Czene K, Hall P. Eriksson M, et al. Among authors: discacciati a. J Clin Oncol. 2021 Jun 10;39(17):1899-1908. doi: 10.1200/JCO.20.02598. Epub 2021 Mar 18. J Clin Oncol. 2021. PMID: 33734864 Free PMC article. Clinical Trial.
MRI-Targeted or Standard Biopsy in Prostate Cancer Screening.
Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, Glaessgen A, Carlsson S, Grönberg H, Nordström T; STHLM3 consortium. Eklund M, et al. Among authors: discacciati a. N Engl J Med. 2021 Sep 2;385(10):908-920. doi: 10.1056/NEJMoa2100852. Epub 2021 Jul 9. N Engl J Med. 2021. PMID: 34237810 Clinical Trial.
Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
Nordström T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, Jäderling F, Eklund M, Grönberg H; STHLM3 study group. Nordström T, et al. Among authors: discacciati a. Lancet Oncol. 2021 Sep;22(9):1240-1249. doi: 10.1016/S1470-2045(21)00348-X. Epub 2021 Aug 13. Lancet Oncol. 2021. PMID: 34391509 Clinical Trial.
78 results